Klaus-Michael Debatin

11PUBLICATIONS
131CO-AUTHORS
Molecular targetsTumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Nov 14, 2023
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation.

Victor G Lui, Manfred Hoenig, Berenice Cabrera-Martinez

|Jan 21, 2022
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy.

Mike-Andrew Westhoff, Marie Schuler-Ortoli, Daniela Zerrinius

|Oct 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.

Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan

|Jun 07, 2021
MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.

Elena Boldrin, Enrico Gaffo, Alexandra Niedermayer

|Nov 22, 2019
Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B-cell acute lymphoblastic leukemia.

Julia Zinngrebe, Ferdinand Schlichtig, Johann M Kraus

Pageof 2

Frequent Collaborators

2 joint publications

Mike-Andrew Westhoff

2 joint publications

Felix Seyfried

2 joint publications

Lüder Hinrich Meyer

1 joint publications

Enrico Gaffo